Bosutinib: A review of preclinical studies in chronic myelogenous leukaemiaBOSCHELLI, Frank; ARNDT, Kim; GAMBACORTI-PASSERINI, Carlo et al.European journal of cancer (1990). 2010, Vol 46, Num 10, pp 1781-1789, issn 0959-8049, 9 p.Article

Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-α and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acidMOLOGNI, Luca; MARCHESI, Edoardo; NIELSEN, Peter E et al.Cancer research (Baltimore). 2001, Vol 61, Num 14, pp 5468-5473, issn 0008-5472Article

Bosutinib: a review of preclinical and clinical studies in chronic myelogenous leukemiaRUSCONI, Francesca; PIAZZA, Rocco; VAGGE, Elisabetta et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 5, pp 701-710, issn 1465-6566, 10 p.Article

Are Chronic Myeloid Leukemia Patients More at Risk for Second Malignancies? A Population-based StudyREBORA, Paola; CZENE, Kamila; ANTOLINI, Laura et al.American journal of epidemiology. 2010, Vol 172, Num 9, pp 1028-1033, issn 0002-9262, 6 p.Article

Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl) nicotinonitrile scaffoldBRANDT, Wiebke; MOLOGNI, Luca; PREU, Lutz et al.European journal of medicinal chemistry. 2010, Vol 45, Num 7, pp 2919-2927, issn 0223-5234, 9 p.Article

Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cellsZUCO, Valentina; SUPINO, Rosanna; RIGHETTI, Sabina C et al.Cancer letters. 2002, Vol 175, Num 1, pp 17-25, issn 0304-3835Article

SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its nuclear signalingLUCE COLUCCIA, Addolorata Maria; BENATI, Daniela; DEKHIL, Hafedh et al.Cancer research (Baltimore). 2006, Vol 66, Num 4, pp 2279-2286, issn 0008-5472, 8 p.Article

ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2. 1-restricted CD8⁺ T-cell epitopesPASSONI, Lorena; SCARDINO, Antonio; BERTAZZOLI, Carla et al.Blood. 2002, Vol 99, Num 6, pp 2100-2106, issn 0006-4971Article

Sensitivity to imatinib but low frequency of the TEL/PDGFRβ fusion protein in chronic myelomonocytic leukemiaGUNBY, Rosalind Helen; CAZZANIGA, Giovanni; TASSI, Elena et al.Haematologica (Roma). 2003, Vol 88, Num 4, pp 408-415, issn 0390-6078, 8 p.Article

Colorectal Tumors Are Effectively Eradicated by Combined Inhibition of β-Catenin, KRAS, and the Oncogenic Transcription Factor ITF2MOLOGNI, Luca; DEKHIL, Hafedh; CECCON, Monica et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 18, pp 7253-7263, issn 0008-5472, 11 p.Article

In vivo T-cell immune response against anaplastic lymphoma kinase in patients with anaplastic large cell lymphomasPASSONI, Lorena; GALLO, Barbara; BIGANZOLI, Elia et al.Haematologica (Roma). 2006, Vol 91, Num 1, pp 48-55, issn 0390-6078, 8 p.Article

Bcl-X_L down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivoCOLUCCIA, Addolorata Maria; PEREGO, Silvia; CLERIS, Loredana et al.Blood. 2004, Vol 103, Num 7, pp 2787-2794, issn 0006-4971, 8 p.Article

Valproic acid enhances bosutinib cytotoxicity in colon cancer cellsMOLOGNI, Luca; CLERIS, Loredana; MAGISTRONI, Vera et al.International journal of cancer (Print). 2009, Vol 124, Num 8, pp 1990-1996, issn 0020-7136, 7 p.Article

Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of diseaseGAMBACORTI-PASSERINI, Carlo; BARNI, Rossella; MARCHESI, Edoardo et al.British journal of haematology. 2001, Vol 112, Num 4, pp 972-974, issn 0007-1048Article

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With ImatinibGAMBACORTI-PASSERINI, Carlo; ANTOLINI, Laura; D'EMILIO, Anna et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 7, pp 553-561, issn 0027-8874, 9 p.Article

Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylatePERSEGHIN, Paolo; GAMBACORTI-PASSERINI, Carlo; PONCHIO, Luisa et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 7, pp 1214-1220, issn 0041-1132, 7 p.Article

BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2PERROTTI, Danilo; CESI, Vincenzo; CALABRETTA, Bruno et al.Nature genetics. 2002, Vol 30, Num 1, pp 48-58, issn 1061-4036Article

Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failureJEAN KHOURY, H; CORTES, Jorge E; KELLY, Virginia et al.Blood. 2012, Vol 119, Num 15, pp 3403-3412, issn 0006-4971, 10 p.Article

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome―positive chronic myeloid leukemia patients with resistance or intolerance to imatinibCORTES, Jorge E; KANTARJIAN, Hagop M; BESSON, Nadine et al.Blood. 2011, Vol 118, Num 17, pp 4567-4576, issn 0006-4971, 10 p.Article

Gynaecomastia in men with chronic myeloid leukaemia after imatinibGAMBACORTI-PASSERINI, Carlo; TORNAGHI, Lucia; CAVAGNINI, Francesco et al.Lancet (British edition). 2003, Vol 361, Num 9373, pp 1954-1956, issn 0140-6736, 3 p.Article

Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA TrialCORTES, Jorge E; KIM, Dong-Wook; GAMBACORTI-PASSERINI, Carlo et al.Journal of clinical oncology. 2012, Vol 30, Num 28, pp 3486-3492, issn 0732-183X, 7 p.Article

Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma PatientsPASSONI, Lorena; LONG, Luca; DEL GROSSO, Federica et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 18, pp 7338-7346, issn 0008-5472, 9 p.Article

Role of α1 acid glycoprotein in the in vivo resistance of human BCR-ABL⁺ leukemic cells to the abl inhibitor STI571GAMBACORTI-PASSERINI, Carlo; BARNI, Rossella; PIOLTELLI, Pietro et al.Journal of the National Cancer Institute. 2000, Vol 92, Num 20, pp 1641-1650, issn 0027-8874Article

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibitionBACHMANN, Petra S; PIAZZA, Rocco G; CAZZANIGA, Giovanni et al.Blood. 2010, Vol 116, Num 16, pp 3013-3022, issn 0006-4971, 10 p.Article

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemiaKANTARJIAN, Hagop; SAWYERS, Charles; TALPAZ, Moshe et al.The New England journal of medicine. 2002, Vol 346, Num 9, pp 645-652, issn 0028-4793Article